title: Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism.
authors.forename: P L
authors.initials: PL
authors.lastname: Bittencourt
authors.forename: S A
authors.initials: SA
authors.lastname: Palacios
authors.forename: E L R
authors.initials: EL
authors.lastname: Cançado
authors.forename: F J
authors.initials: FJ
authors.lastname: Carrilho
authors.forename: G
authors.initials: G
authors.lastname: Porta
authors.forename: J
authors.initials: J
authors.lastname: Kalil
authors.forename: A C
authors.initials: AC
authors.lastname: Goldberg
mesh_terms: D000293:Adolescent; D000328:Adult; D001938:Brazil; D016022:Case-Control Studies; D002648:Child; D015209:Cholangitis, Sclerosing / Q000235:genetics*; D005260:Female; D020022:Genetic Predisposition to Disease; D006684:HLA-DR Antigens / Q000235:genetics*; D059811:HLA-DRB1 Chains; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic / Q000235:genetics; D011401:Promoter Regions, Genetic / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics*
chemical_list: D006684:HLA-DR Antigens; D059811:HLA-DRB1 Chains; D014409:Tumor Necrosis Factor-alpha